Main menu

A novel assay based on Oxford Nanopore technology for potential mass screening of Klinefelter syndrome


Abstract

Klinefelter syndrome (KS) is the most common and most underdiagnosed sex chromosomal abnormality, with a prevalence of 1 in 500 male births, leading to a variety of clinical features including infertility. Multiple studies demonstrate that if treated in a timely manner (e.g. with hormonal therapy and early fertility management) boys affected with KS can have a normal life, with a 25% chance to achieve fertility. The key element in successful treatment of KS is a timely identification. Here, we present research demonstrating a cost-effective, end-to-end assay with potential future utility for postnatal detection of KS based on Oxford Nanopore technology. The research suggests the technology could be applied for detection of any other genetic disorder.

Authors: Anne Kristine Schack

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag